1120 related articles for article (PubMed ID: 25483963)
1. Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression.
Giegerich AK; Kuchler L; Sha LK; Knape T; Heide H; Wittig I; Behrends C; Brüne B; von Knethen A
Autophagy; 2014; 10(11):1937-52. PubMed ID: 25483963
[TBL] [Abstract][Full Text] [Related]
2. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
3. Regulation of autophagy by E3 ubiquitin ligase RNF216 through BECN1 ubiquitination.
Xu C; Feng K; Zhao X; Huang S; Cheng Y; Qian L; Wang Y; Sun H; Jin M; Chuang TH; Zhang Y
Autophagy; 2014; 10(12):2239-50. PubMed ID: 25484083
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of MTOR promotes autophagy-mediated epithelial injury in particulate matter-induced airway inflammation.
Wu YF; Li ZY; Dong LL; Li WJ; Wu YP; Wang J; Chen HP; Liu HW; Li M; Jin CL; Huang HQ; Ying SM; Li W; Shen HH; Chen ZH
Autophagy; 2020 Mar; 16(3):435-450. PubMed ID: 31203721
[TBL] [Abstract][Full Text] [Related]
5. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
6. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Yao RQ; Ren C; Xia ZF; Yao YM
Autophagy; 2021 Feb; 17(2):385-401. PubMed ID: 32048886
[TBL] [Abstract][Full Text] [Related]
7. The exploitation of host autophagy and ubiquitin machinery by
Shariq M; Quadir N; Alam A; Zarin S; Sheikh JA; Sharma N; Samal J; Ahmad U; Kumari I; Hasnain SE; Ehtesham NZ
Autophagy; 2023 Jan; 19(1):3-23. PubMed ID: 35000542
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation.
Min Y; Kim MJ; Lee S; Chun E; Lee KY
Autophagy; 2018; 14(8):1347-1358. PubMed ID: 29929436
[TBL] [Abstract][Full Text] [Related]
9. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia.
Lee JW; Nam H; Kim LE; Jeon Y; Min H; Ha S; Lee Y; Kim SY; Lee SJ; Kim EK; Yu SW
Autophagy; 2019 May; 15(5):753-770. PubMed ID: 30523761
[TBL] [Abstract][Full Text] [Related]
10. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
12. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
[TBL] [Abstract][Full Text] [Related]
13. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation.
Kinsella S; Fichtner M; Watters O; König HG; Prehn JHM
J Neuroinflammation; 2018 May; 15(1):130. PubMed ID: 29720226
[TBL] [Abstract][Full Text] [Related]
14. SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect.
Zhang B; Chen H; Ouyang J; Xie Y; Chen L; Tan Q; Du X; Su N; Ni Z; Chen L
Autophagy; 2020 Jul; 16(7):1262-1278. PubMed ID: 31500508
[TBL] [Abstract][Full Text] [Related]
15. Emerging views of mitophagy in immunity and autoimmune diseases.
Xu Y; Shen J; Ran Z
Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392
[TBL] [Abstract][Full Text] [Related]
16. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
[TBL] [Abstract][Full Text] [Related]
17. Autophagy in the physiological endometrium and cancer.
Devis-Jauregui L; Eritja N; Davis ML; Matias-Guiu X; Llobet-Navàs D
Autophagy; 2021 May; 17(5):1077-1095. PubMed ID: 32401642
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
19. Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclin1-PI3KC3 Pathway.
Kuang M; Cen Y; Qin R; Shang S; Zhai Z; Liu C; Pan X; Zhou H
Cell Physiol Biochem; 2018; 47(2):475-488. PubMed ID: 29794440
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.
Lin YC; Huang DY; Chu CL; Lin YL; Lin WW
Sci Signal; 2013 Aug; 6(289):ra71. PubMed ID: 23962979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
